GV

GV

USD

Visionary Holdings Inc. Common Shares

$1.470+0.030 (2.083%)

即時價格

Consumer Defensive
Education & Training Services
加拿大

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$1.440

最高

$1.490

最低

$1.420

交易量

0.03M

公司基本面

市值

6.0M

行業

Education & Training Services

國家

Canada

交易統計

平均交易量

1.91M

交易所

NCM

貨幣

USD

52週範圍

最低 $1.022當前 $1.470最高 $9.6

相關新聞

PR Newswire

Visionary Holdings (Nasdaq: GV) Launches Stem Cell-Based Anti-Aging Product Line, Accelerating Expansion into Asia's Premium Regenerative Medicine Market

Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced that its ...

查看更多
Visionary Holdings (Nasdaq: GV) Launches Stem Cell-Based Anti-Aging Product Line, Accelerating Expansion into Asia's Premium Regenerative Medicine Market
PR Newswire

Visionary Holdings Inc. Announces Successful Leadership Transition: Elite Governance Team Leads the Way, Standardized Structure Empowers High-Quality Development

At 10:00 a.m. (Eastern Time, USA) on November 3, 2025, Visionary Holdings Inc. (hereinafter referred to as the "Company", NASDAQ: GV) successfully...

查看更多
Visionary Holdings Inc. Announces Successful Leadership Transition: Elite Governance Team Leads the Way, Standardized Structure Empowers High-Quality Development
PR Newswire

Visionary Holdings Inc. Receives Nasdaq Notification Regarding Delayed Form 20-F Filing

Visionary Holdings Inc. (Nasdaq: GV) ("Visionary" or the "Company"), a private education service provider integrating technology and innovation,...

查看更多
Visionary Holdings Inc. Receives Nasdaq Notification Regarding Delayed Form 20-F Filing
PR Newswire

Visionary Holdings Launches Toronto-Based Joint Venture to Drive Global Commercialization of Innovative Stem Cell Therapy for Diabetes Remission, Targeting a $150 Billion Market Opportunity

Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced the...

查看更多
Visionary Holdings Launches Toronto-Based Joint Venture to Drive Global Commercialization of Innovative Stem Cell Therapy for Diabetes Remission, Targeting a $150 Billion Market Opportunity